| How to interpret and use COVID-19 serology and immunology tests DSY Ong, PC Fragkou, VA Schweitzer, RF Chemaly, CD Moschopoulos, ... Clinical Microbiology and Infection 27 (7), 981-986, 2021 | 158* | 2021 |
| ESCMID rapid guidelines for assessment and management of long COVID D Yelin, CD Moschopoulos, I Margalit, E Gkrania-Klotsas, F Landi, ... Clinical Microbiology and Infection 28 (7), 955-972, 2022 | 134 | 2022 |
| Review of trials currently testing treatment and prevention of COVID-19 PC Fragkou, D Belhadi, N Peiffer-Smadja, CD Moschopoulos, FX Lescure, ... Clinical Microbiology and Infection 26 (8), 988-998, 2020 | 121 | 2020 |
| Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial M Trøseid, JR Arribas, L Assoumou, AR Holten, J Poissy, V Terzić, ... Critical care 27 (1), 9, 2023 | 29 | 2023 |
| Update in viral infections in the intensive care unit PC Fragkou, CD Moschopoulos, E Karofylakis, T Kelesidis, S Tsiodras Frontiers in Medicine 8, 575580, 2021 | 28 | 2021 |
| Cardiovascular disease and risk assessment in people living with HIV: Current practices and novel perspectives PC Fragkou, CD Moschopoulos, D Dimopoulou, H Triantafyllidi, D Birmpa, ... Hellenic Journal of Cardiology 71, 42-54, 2023 | 26 | 2023 |
| Performance of point-of care molecular and antigen-based tests for SARS-CoV-2: a living systematic review and meta-analysis PC Fragkou, CD Moschopoulos, D Dimopoulou, DSY Ong, K Dimopoulou, ... Clinical Microbiology and Infection 29 (3), 291-301, 2023 | 17 | 2023 |
| New insights into the fluid management in patients with septic shock CD Moschopoulos, D Dimopoulou, A Dimopoulou, K Dimopoulou, ... Medicina 59 (6), 1047, 2023 | 16 | 2023 |
| Intensity and dynamics of anti-SARS-CoV-2 immune responses after BNT162b2 MRNA vaccination: Implications for public health vaccination strategies M Speletas, I Voulgaridi, S Sarrou, A Dadouli, VA Mouchtouri, DJ Nikoulis, ... Vaccines 10 (2), 316, 2022 | 15 | 2022 |
| Switching from tenofovir disoproxil to tenofovir alafenamide fumarate: impact on cardiovascular risk and lipid profile in people living with HIV, an observational study CD Moschopoulos, K Protopapas, K Thomas, D Kavatha, ... AIDS Research and Human Retroviruses 39 (2), 68-75, 2023 | 7 | 2023 |
| Host immune responses and possible therapeutic targets for viral respiratory tract infections in susceptible populations: a narrative review PC Fragkou, CD Moschopoulos, R Reiter, T Berger, C Skevaki Clinical Microbiology and Infection 28 (10), 1328-1334, 2022 | 7 | 2022 |
| Insights into CD24 and exosome physiology and potential role in view of recent advances in COVID-19 therapeutics: a narrative review G Tsioulos, I Grigoropoulos, CD Moschopoulos, S Shapira, G Poulakou, ... Life 12 (10), 1472, 2022 | 7 | 2022 |
| Cognitive impairment in people living with HIV: mechanisms, controversies, and future perspectives CD Moschopoulos, K Alford, A Antoniadou, JH Vera Trends in Molecular Medicine, 2024 | 6 | 2024 |
| Long-COVID-pathophysiology, current concepts and future directions C Skevaki, CD Moschopoulos, PC Fragkou, K Grote, E Schieffer, ... Journal of Allergy and Clinical Immunology, 2024 | 4 | 2024 |
| Multimodal approach to neurocognitive function in people living with HIV in the cART era: a comprehensive review CD Moschopoulos, E Stanitsa, K Protopapas, D Kavatha, ... Life 14 (4), 508, 2024 | 3 | 2024 |
| Effect of neutralizing monoclonal antibody treatment on early trajectories of virologic and immunologic biomarkers in patients hospitalized with COVID-19 TO Jensen, GA Grandits, MK Jain, TA Murray, B Grund, K Shaw-Saliba, ... The Journal of infectious diseases 229 (3), 671-679, 2024 | 3 | 2024 |
| Endothelial glycocalyx integrity in treatment-naïve people living with HIV before and one year after antiretroviral treatment initiation PC Fragkou, I Ikonomidis, D Benas, D Kavatha, CD Moschopoulos, ... Viruses 15 (7), 1505, 2023 | 3 | 2023 |
| Mpox and Lessons Learned in the Light of the Recent Outbreak: A Narrative Review K Protopapas, D Dimopoulou, N Kalesis, K Akinosoglou, ... Viruses 16 (10), 1620, 2024 | 2 | 2024 |
| Antibody Response Following Pre-Exposure Immunization Against Rabies in High-Risk Professionals G Dougas, M Mavrouli, G Vrioni, T Lytras, K Mellou, S Metallidis, ... Vector-Borne and Zoonotic Diseases 20 (4), 303-309, 2020 | 2 | 2020 |
| Review and methodological analysis of trials currently testing treatment and prevention options for the novel coronavirus disease (COVID-19) globally. PC Fragkou, D Belhadi, N Peiffer-Smadja, CD Moschopoulos, FX Lescure, ... | 2 | 2020 |
